Viewing Study NCT01786395


Ignite Creation Date: 2025-12-24 @ 1:40 PM
Ignite Modification Date: 2026-01-24 @ 3:58 PM
Study NCT ID: NCT01786395
Status: TERMINATED
Last Update Posted: 2016-01-29
First Post: 2013-01-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa
Sponsor: R-Tech Ueno, Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Retinitis Pigmentosa View
Keywords:

Keywords

Keyword Brief Keyword Text View
None UF-021 View
None unoprostone View
None rp View